98 related articles for article (PubMed ID: 2198791)
1. Low-dose total body irradiation in non-Hodgkin lymphoma: short- and long-term toxicity and prognostic factor.
De Neve WJ; Lybeert ML; Meerwaldt JH
Am J Clin Oncol; 1990 Aug; 13(4):280-4. PubMed ID: 2198791
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of low dose total body irradiation for advanced non-Hodgkin lymphoma.
Lybeert ML; Meerwaldt JH; Deneve W
Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1167-72. PubMed ID: 3301759
[TBL] [Abstract][Full Text] [Related]
3. Involved-field irradiation in combination with total-body irradiation (TBI) does not increase short-term toxicity compared to TBI alone in patients with advanced-stage low-grade non-Hodgkin lymphoma.
Ott M; Schmidberger H; Wörmann B; Albrecht CF; Pradier O; Hess CF
Strahlenther Onkol; 2002 May; 178(5):245-51. PubMed ID: 12082683
[TBL] [Abstract][Full Text] [Related]
4. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
[TBL] [Abstract][Full Text] [Related]
5. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
6. The role of low-dose total body irradiation in treatment of non-Hodgkin's lymphoma: a new look at an old method.
Safwat A
Radiother Oncol; 2000 Jul; 56(1):1-8. PubMed ID: 10869748
[TBL] [Abstract][Full Text] [Related]
7. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy.
Krol AD; Berenschot HW; Doekharan D; Henzen-Logmans S; van der Holt B; van 't Veer MB
Radiother Oncol; 2001 Mar; 58(3):251-5. PubMed ID: 11230885
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
10. Non-Hodgkin lymphoma: whole-abdomen irradiation as an adjuvant to chemotherapy.
Valicenti RK; Wasserman TH; Monyak DJ; Kucik NA
Radiology; 1994 Aug; 192(2):571-6. PubMed ID: 8029434
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation.
Abrams RA; Liu PJ; Ambinder RF; Haulk TL; Korman LT; Herman MG; Jones RJ
Radiology; 1997 Jun; 203(3):865-70. PubMed ID: 9169718
[TBL] [Abstract][Full Text] [Related]
12. The potential palliative role and possible immune modulatory effects of low-dose total body irradiation in relapsed or chemo-resistant non-Hodgkin's lymphoma.
Safwat A; Bayoumy Y; El-Sharkawy N; Shaaban K; Mansour O; Kamel A
Radiother Oncol; 2003 Oct; 69(1):33-6. PubMed ID: 14597354
[TBL] [Abstract][Full Text] [Related]
13. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
Schlembach PJ; Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1107-10. PubMed ID: 11072169
[TBL] [Abstract][Full Text] [Related]
14. Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group).
Economopoulos T; Fountzilas G; Kostourou A; Daniilidis J; Pavlidis N; Andreopoulou H; Nicolaou A; Papageorgiou E; Mellou S; Dervenoulas J; Stathakis N
Anticancer Res; 1998; 18(6B):4655-60. PubMed ID: 9891536
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
Ott OJ; Rödel C; Gramatzki M; Niedobitek G; Sauer R; Grabenbauer GG
Strahlenther Onkol; 2003 Oct; 179(10):694-701. PubMed ID: 14566478
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy for treatment of localized gastrointestinal non-Hodgkin's lymphoma.
Kocher M; Müller RP; Ross D; Hoederath A; Sack H
Radiother Oncol; 1997 Jan; 42(1):37-41. PubMed ID: 9132824
[TBL] [Abstract][Full Text] [Related]
17. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience.
Wong WW; Schild SE; Halyard MY; Schomberg PJ
J Surg Oncol; 2002 May; 80(1):19-25; discussion 26. PubMed ID: 11967901
[TBL] [Abstract][Full Text] [Related]
18. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
19. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
Kamath SS; Marcus RB; Lynch JW; Mendenhall NP
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):563-8. PubMed ID: 10348285
[TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
Hoederath A; Sack H; Stuschke M; Lampka E
Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
